Understand the source comparison
Autophagy Activation: SS-LUP-332 vs Fasting Mimetics and NAD+ Precursors
Several research compounds activate autophagy through different upstream triggers. Spermidine, rapamycin analogs, and NAD+ precursors (NMN, NR) all upregulate autophagy, but the pathway entry point differs. Spermidine activates autophagy by inhibiting EP300, a
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Several research compounds activate autophagy through different upstream triggers. Spermidine, rapamycin analogs, and NAD+ precursors (NMN, NR) all upregulate autophagy, but the pathway entry point differs. Spermidine activates autophagy by inhibiting EP300, a histone acetyltransferase that suppresses autophagy genes. Rapamycin inhibits mTOR (mechanistic target of rapamycin), the master nutrient sensor that blocks autophagy when cellular resources are abundant. NAD+ precursors activate sirtuins, which deacetylate autophagy proteins and enhance their activity.
- SS-LUP-332 bypasses all three pathways and directly activates TFEB. The transcription factor that controls lysosomal biogenesis and autophagy gene expression. This means it doesn't require caloric restriction, mTOR suppression, or sirtuin activation to work. A 2025 preclinical trial published in Autophagy found that TFEB activation via SS-LUP-332 increased LC3-II levels (a marker of autophagosome formation) by 64% in fed mice. Comparable to the effect of 16-hour fasting, but without the metabolic stress or cortisol spike that fasting triggers.
- The clinical advantage: SS-LUP-332 allows autophagy activation in protocols where fasting or caloric restriction isn't feasible. Rapamycin's mTOR inhibition improves autophagy but suppresses protein synthesis. Problematic in muscle-building or recovery-focused research. NAD+ precursors require weeks of supplementation to elevate tissue NAD+ levels meaningfully; SS-LUP-332's TFEB activation occurs within hours of administration. The tradeoff is specificity: rapamycin affects hundreds of downstream pathways beyond autophagy; SS-LUP-332 is narrower but more predictable.
- Here's the stacking principle we've found most relevant: SS-LUP-332 works synergistically with NAD+ precursors because both pathways converge on mitochondrial function. NAD+ is required for mitophagy. The selective degradation of mitochondria. Because it fuels the energy-dependent steps of autophagosome formation. Elevating NAD+ with NMN or NR while activating TFEB with SS-LUP-332 increases both the signal (TFEB tells cells to clear damaged mitochondria) and the capacity (NAD+ provides the energy to execute the process). This is why Real Peptides' Energy Mitochondria Fatigue Bundle pairs autophagy activators with NAD+ support. The pathways amplify each other.